ArticleCardiovascular and interventional radiology2026
Single-Session Percutaneous Cholangioscopy for High-Risk Patients with Biliary Stone Disease.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Session Percutaneous Cholangioscopy: Advancing High-Risk Biliary Stone Management Toward Definitive Therapy.Cardiovascular and interventional radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the technical and clinical success, as well as the safety, of single-operator, single-session percutaneous cholangioscopy for the management of biliary stone disease. MATERIALS AND
methodsThirty-four non-surgical patients (median age 69 years; 14 female, 20 male) from two tertiary care hospitals underwent 37 percutaneous cholangioscopy-guided stone extraction procedures between March 2023 and August 2025. Patient characteristics, procedural details, technical and clinical success, and complications were retrospectively reviewed.
resultsTwenty-six patients underwent percutaneous cholecystostomy (PC) and eight underwent percutaneous transhepatic biliary drainage (PTBD) prior to cholangioscopy. Primary technical success was 91.2% (31/34; 95% CI, 76.3-98.1)-88.5% in the PC cohort (23/26) and 100% in the PTBD cohort (8/8). After three repeat procedures, secondary technical success reached 100%. Clinical success, defined as the absence of recurrent cholecystitis or biliary colic, was achieved in 91.2% of patients over a median follow-up of 413 days. The median drain dwell time was 113 days, with a median interval of 14 days from stone extraction to drain removal. Two procedure-related complications occurred-one cystic duct injury and one pleural effusion (CIRSE classification 1a and 3b, respectively)-along with one non-procedure-related complication of prolonged delirium (CIRSE classification 3b).
conclusionSingle-session percutaneous cholangioscopy-guided biliary stone management demonstrates high technical and clinical success with minimal complications and appears to be a viable treatment option for high-risk patients who are not candidates for surgery or peroral endoscopic interventions.
Indexed as
Identifiers
41345751What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.